ID APEX1_MOUSE Reviewed; 317 AA.
AC P28352;
DT 01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT 23-JAN-2007, sequence version 2.
DT 03-APR-2013, entry version 134.
DE RecName: Full=DNA-(apurinic or apyrimidinic site) lyase;
DE EC=3.1.-.-;
DE EC=4.2.99.18;
DE AltName: Full=APEX nuclease;
DE Short=APEN;
DE AltName: Full=Apurinic-apyrimidinic endonuclease 1;
DE Short=AP endonuclease 1;
DE AltName: Full=REF-1;
DE AltName: Full=Redox factor-1;
DE Contains:
DE RecName: Full=DNA-(apurinic or apyrimidinic site) lyase, mitochondrial;
GN Name=Apex1; Synonyms=Ape, Apex, Ref1;
OS Mus musculus (Mouse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC Muroidea; Muridae; Murinae; Mus; Mus.
OX NCBI_TaxID=10090;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC STRAIN=NFS; TISSUE=Spleen;
RX PubMed=1939131;
RA Seki S., Akiyama K., Watanabe S., Hatsushika M., Ikeda S., Tsutsui K.;
RT "cDNA and deduced amino acid sequence of a mouse DNA repair enzyme
RT (APEX nuclease) with significant homology to Escherichia coli
RT exonuclease III.";
RL J. Biol. Chem. 266:20797-20802(1991).
RN [2]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=129; TISSUE=Embryo;
RX PubMed=7533013; DOI=10.1007/BF00426079;
RA Takiguchi Y., Chen D.J.;
RT "Genomic structure of the mouse apurinic/apyrimidinic endonuclease
RT gene.";
RL Mamm. Genome 5:717-722(1994).
RN [3]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=BALB/c; TISSUE=Blood;
RX PubMed=7782087; DOI=10.1016/0888-7543(95)80083-X;
RA Akiyama K., Nagao K., Oshida T., Tsutsui K., Yoshida M.C., Seki S.;
RT "Cloning, sequence analysis, and chromosomal assignment of the mouse
RT Apex gene.";
RL Genomics 26:63-69(1995).
RN [4]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC STRAIN=C57BL/6; TISSUE=Brain;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA
RT project: the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [5]
RP PROTEIN SEQUENCE OF 2-22, AND CHARACTERIZATION.
RC TISSUE=Ascites;
RX PubMed=1716153; DOI=10.1016/0167-4838(91)90024-T;
RA Seki S., Ikeda S., Watanabe S., Hatsushika M., Tsutsui K., Akiyama K.,
RA Zhang B.;
RT "A mouse DNA repair enzyme (APEX nuclease) having exonuclease and
RT apurinic/apyrimidinic endonuclease activities: purification and
RT characterization.";
RL Biochim. Biophys. Acta 1079:57-64(1991).
RN [6]
RP SUBCELLULAR LOCATION.
RX PubMed=16617147; DOI=10.1093/nar/gkl177;
RA Chattopadhyay R., Wiederhold L., Szczesny B., Boldogh I., Hazra T.K.,
RA Izumi T., Mitra S.;
RT "Identification and characterization of mitochondrial abasic (AP)-
RT endonuclease in mammalian cells.";
RL Nucleic Acids Res. 34:2067-2076(2006).
RN [7]
RP FUNCTION, AND SUBCELLULAR LOCATION.
RX PubMed=18025127; DOI=10.1084/jem.20071289;
RA Guikema J.E., Linehan E.K., Tsuchimoto D., Nakabeppu Y., Strauss P.R.,
RA Stavnezer J., Schrader C.E.;
RT "APE1- and APE2-dependent DNA breaks in immunoglobulin class switch
RT recombination.";
RL J. Exp. Med. 204:3017-3026(2007).
RN [8]
RP FUNCTION.
RX PubMed=19556307; DOI=10.1093/intimm/dxp061;
RA Sabouri Z., Okazaki I.M., Shinkura R., Begum N., Nagaoka H.,
RA Tsuchimoto D., Nakabeppu Y., Honjo T.;
RT "Apex2 is required for efficient somatic hypermutation but not for
RT class switch recombination of immunoglobulin genes.";
RL Int. Immunol. 21:947-955(2009).
RN [9]
RP PHOSPHORYLATION AT THR-232, INTERACTION WITH CDK5, AND MUTAGENESIS OF
RP THR-232.
RX PubMed=20473298; DOI=10.1038/ncb2058;
RA Huang E., Qu D., Zhang Y., Venderova K., Haque M.E., Rousseaux M.W.C.,
RA Slack R.S., Woulfe J.M., Park D.S.;
RT "The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1
RT phosphorylation in neuronal death.";
RL Nat. Cell Biol. 12:563-571(2010).
CC -!- FUNCTION: Multifunctional protein that plays a central role in the
CC cellular response to oxidative stress. The two major activities of
CC APEX1 in DNA repair and redox regulation of transcriptional
CC factors. Functions as a apurinic/apyrimidinic (AP)
CC endodeoxyribonuclease in the DNA base excision repair (BER)
CC pathway of DNA lesions induced by oxidative and alkylating agents.
CC Initiates repair of AP sites in DNA by catalyzing hydrolytic
CC incision of the phosphodiester backbone immediately adjacent to
CC the damage, generating a single-strand break with 5'-deoxyribose
CC phosphate and 3'-hydroxyl ends. Does also incise at AP sites in
CC the DNA strand of DNA/RNA hybrids, single-stranded DNA regions of
CC R-loop structures, and single-stranded RNA molecules. Has a 3'-5'
CC exoribonuclease activity on mismatched deoxyribonucleotides at the
CC 3' termini of nicked or gapped DNA molecules during short-patch
CC BER. Possesses a DNA 3' phosphodiesterase activity capable of
CC removing lesions (such as phosphoglycolate) blocking the 3' side
CC of DNA strand breaks. May also play a role in the epigenetic
CC regulation of gene expression by participating in DNA
CC demethylation. Acts as a loading factor for POLB onto non-incised
CC AP sites in DNA and stimulates the 5'-terminal deoxyribose 5'-
CC phosphate (dRp) excision activity of POLB. Plays a role in the
CC protection from granzymes-mediated cellular repair leading to cell
CC death. Also involved in the DNA cleavage step of class switch
CC recombination (CSR). On the other hand, APEX1 also exerts
CC reversible nuclear redox activity to regulate DNA binding affinity
CC and transcriptional activity of transcriptional factors by
CC controlling the redox status of their DNA-binding domain, such as
CC the FOS/JUN AP-1 complex after exposure to IR. Involved in
CC calcium-dependent down-regulation of parathyroid hormone (PTH)
CC expression by binding to negative calcium response elements
CC (nCaREs). Together with HNRNPL or the dimer XRCC5/XRCC6,
CC associates with nCaRE, acting as an activator of transcriptional
CC repression. Stimulates the YBX1-mediated MDR1 promoter activity,
CC when acetylated at Lys-6 and Lys-7, leading to drug resistance.
CC Acts also as an endoribonuclease involved in the control of
CC single-stranded RNA metabolism. Plays a role in regulating MYC
CC mRNA turnover by preferentially cleaving in between UA and CA
CC dinucleotides of the MYC coding region determinant (CRD). In
CC association with NMD1, plays a role in the rRNA quality control
CC process during cell cycle progression. Associates, together with
CC YBX1, on the MDR1 promoter. Together with NPM1, associates with
CC rRNA. Binds DNA and RNA.
CC -!- CATALYTIC ACTIVITY: The C-O-P bond 3' to the apurinic or
CC apyrimidinic site in DNA is broken by a beta-elimination reaction,
CC leaving a 3'-terminal unsaturated sugar and a product with a
CC terminal 5'-phosphate.
CC -!- COFACTOR: Magnesium. Can also utilize manganese. Probably binds
CC two magnesium or manganese ions per subunit (By similarity).
CC -!- ENZYME REGULATION: NPM1 stimulates endodeoxyribonuclease activity
CC on double-stranded DNA with AP sites, but inhibits
CC endoribonuclease activity on single-stranded RNA containing AP
CC sites (By similarity).
CC -!- SUBUNIT: Monomer. Homodimer; disulfide-linked. Component of the
CC SET complex, composed at least of APEX1, GZMA, SET, ANP32A, HMGB2
CC and NME1. Associates with the dimer XRCC5/XRCC6 in a DNA-dependent
CC manner. Interacts with SIRT1; the interaction is increased in the
CC context of genotoxic stress. Interacts with HDAC1, HDAC2 and
CC HDAC3; the interactions are not dependent on the APEX1 acetylation
CC status. Interacts with XRCC1; the interaction is induced by SIRT1
CC and increased with the APEX1 acetylated form. Interacts with NPM1
CC (via N-terminal domain); the interaction is RNA-dependent and
CC decreases in hydrogen peroxide-damaged cells. Interacts (via N-
CC terminus) with YBX1 (via C-terminus); the interaction is increased
CC in presence of APEX1 acetylated at Lys-6 and Lys-7. Interacts with
CC HNRNPL; the interaction is DNA-dependent. Interacts (via N-
CC terminus) with KPNA1 and KPNA2. Interacts with TXN; the
CC interaction stimulates the FOS/JUN AP-1 complex DNA-binding
CC activity in a redox-dependent manner. Interacts with GZMA, KRT8,
CC MDM2, POLB, PRDX6, PRPF19, RPLP0, TOMM20 and WDR77 (By
CC similarity). Binds to CDK5.
CC -!- SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus (By similarity).
CC Nucleus speckle (By similarity). Endoplasmic reticulum (By
CC similarity). Cytoplasm. Note=Colocalized with SIRT1 in the
CC nucleus. Colocalized with YBX1 in nuclear speckles after genotoxic
CC stress. Together with OGG1 is recruited to nuclear speckles in
CC UVA-irradiated cells. Colocalized with nucleolin and NPM1 in the
CC nucleolus. Its nucleolar localization is cell cycle dependent and
CC requires active rRNA transcription. Colocalized with calreticulin
CC in the endoplasmic reticulum. Translocation from the nucleus to
CC the cytoplasm is stimulated in presence of nitric oxide (NO) and
CC function in a CRM1-dependent manner, possibly as a consequence of
CC demasking a nuclear export signal (amino acid position 63-79). S-
CC nitrosylation at Cys-92 and Cys-309 regulates its nuclear-
CC cytosolic shuttling. Ubiquitinated form is localized predominantly
CC in the cytoplasm. Detected in the cytoplasm of B-cells stimulated
CC to switch (By similarity).
CC -!- SUBCELLULAR LOCATION: DNA-(apurinic or apyrimidinic site) lyase,
CC mitochondrial: Mitochondrion. Note=Translocation from the
CC cytoplasm to the mitochondria is mediated by ROS signaling and
CC cleavage mediated by granzyme A. Tom20-dependent translocated
CC mitochondrial APEX1 level is significantly increased after
CC genotoxic stress (By similarity). The cleaved APEX2 is only
CC detected in mitochondria.
CC -!- TISSUE SPECIFICITY: Expressed in both resting and stimulated B
CC cells stimulated to switch (at protein level).
CC -!- DOMAIN: The N-terminus contains the redox activity while the C-
CC terminus exerts the DNA AP-endodeoxyribonuclease activity; both
CC function are independent in their actions. An unconventional
CC mitochondrial targeting sequence (MTS) is harbored within the C-
CC terminus, that appears to be masked by the N-terminal sequence
CC containing the nuclear localization signal (NLS), that probably
CC blocks the interaction between the MTS and Tom proteins (By
CC similarity).
CC -!- PTM: Phosphorylated. Phosphorylation by kinase PKC or casein
CC kinase CK2 results in enhanced redox activity that stimulates
CC binding of the FOS/JUN AP-1 complex to its cognate binding site.
CC AP-endodeoxyribonuclease activity is not affected by CK2-mediated
CC phosphorylation (By similarity). Phosphorylation of Thr-232 by
CC CDK5 in response to MPP(+)/MPTP (1-methyl-4-phenylpyridinium)
CC reduces AP-endodeoxyribonuclease activity resulting in
CC accumulation of DNA damage and contributing to neuronal death.
CC -!- PTM: Acetylated on Lys-6 and Lys-7. Acetylation is increased by
CC the transcriptional coactivator EP300 acetyltransferase, genotoxic
CC agents like H(2)O(2) and methyl methanesulfonate (MMS).
CC Acetylation increases its binding affinity to the negative calcium
CC response element (nCaRE) DNA promoter. The acetylated form induces
CC a stronger binding of YBX1 to the Y-box sequence in the MDR1
CC promoter than the unacetylated form. Deacetylated on lysines. Lys-
CC 6 and Lys-7 are deacetylated by SIRT1 (By similarity).
CC -!- PTM: Cleaved at Lys-30 by granzyme A to create the mitochondrial
CC form; leading in reduction of binding to DNA, AP
CC endodeoxyribonuclease activity, redox activation of transcription
CC factors and to enhanced cell death. Cleaved by granzyme K; leading
CC to intracellular ROS accumulation and enhanced cell death after
CC oxidative stress (By similarity).
CC -!- PTM: Cys-64 and Cys-92 are nitrosylated in response to nitric
CC oxide (NO) and lead to the exposure of the nuclear export signal
CC (NES) (By similarity).
CC -!- PTM: Ubiquitinated by MDM2; leading to translocation to the
CC cytoplasm and proteasomal degradation (By similarity).
CC -!- MISCELLANEOUS: The specific activity of the cleaved mitochondrial
CC endodeoxyribonuclease appeared to be about 3-fold higher than of
CC the full-length form. Extract of mitochondria, but not of nuclei
CC or cytosol, cleaves recombinant APEX1 to generate a mitochondrial
CC APEX1-sized product (By similarity).
CC -!- SIMILARITY: Belongs to the DNA repair enzymes AP/ExoA family.
CC -----------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution-NoDerivs License
CC -----------------------------------------------------------------------
DR EMBL; D90374; BAA14382.1; -; mRNA.
DR EMBL; U12273; AAC13769.1; -; Genomic_DNA.
DR EMBL; D38077; BAA07270.1; -; Genomic_DNA.
DR EMBL; BC052401; AAH52401.1; -; mRNA.
DR IPI; IPI00224152; -.
DR PIR; A39500; A39500.
DR RefSeq; NP_033817.1; NM_009687.2.
DR UniGene; Mm.203; -.
DR ProteinModelPortal; P28352; -.
DR SMR; P28352; 43-317.
DR STRING; 10090.ENSMUSP00000042602; -.
DR PhosphoSite; P28352; -.
DR PaxDb; P28352; -.
DR PRIDE; P28352; -.
DR Ensembl; ENSMUST00000049411; ENSMUSP00000042602; ENSMUSG00000035960.
DR GeneID; 11792; -.
DR KEGG; mmu:11792; -.
DR CTD; 328; -.
DR MGI; MGI:88042; Apex1.
DR eggNOG; COG0708; -.
DR HOGENOM; HOG000034586; -.
DR HOVERGEN; HBG050531; -.
DR InParanoid; P28352; -.
DR KO; K10771; -.
DR OMA; TAYAYTF; -.
DR NextBio; 279621; -.
DR ArrayExpress; P28352; -.
DR Bgee; P28352; -.
DR CleanEx; MM_APEX1; -.
DR Genevestigator; P28352; -.
DR GermOnline; ENSMUSG00000035960; Mus musculus.
DR GO; GO:0005813; C:centrosome; IEA:Compara.
DR GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR GO; GO:0016607; C:nuclear speck; ISS:UniProtKB.
DR GO; GO:0005730; C:nucleolus; ISS:UniProtKB.
DR GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR GO; GO:0005667; C:transcription factor complex; IEA:Compara.
DR GO; GO:0008408; F:3'-5' exonuclease activity; ISS:UniProtKB.
DR GO; GO:0031490; F:chromatin DNA binding; ISS:UniProtKB.
DR GO; GO:0003684; F:damaged DNA binding; ISS:UniProtKB.
DR GO; GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; ISS:UniProtKB.
DR GO; GO:0004521; F:endoribonuclease activity; IEA:Compara.
DR GO; GO:0046872; F:metal ion binding; ISS:UniProtKB.
DR GO; GO:0016491; F:oxidoreductase activity; ISS:UniProtKB.
DR GO; GO:0008081; F:phosphoric diester hydrolase activity; IEA:Compara.
DR GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR GO; GO:0016890; F:site-specific endodeoxyribonuclease activity, specific for altered base; ISS:UniProtKB.
DR GO; GO:0003713; F:transcription coactivator activity; ISS:UniProtKB.
DR GO; GO:0007568; P:aging; IEA:Compara.
DR GO; GO:0045454; P:cell redox homeostasis; IDA:MGI.
DR GO; GO:0071320; P:cellular response to cAMP; IEA:Compara.
DR GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Compara.
DR GO; GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Compara.
DR GO; GO:0080111; P:DNA demethylation; ISS:UniProtKB.
DR GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR GO; GO:0006281; P:DNA repair; ISS:UniProtKB.
DR GO; GO:0014912; P:negative regulation of smooth muscle cell migration; IEA:Compara.
DR GO; GO:0045739; P:positive regulation of DNA repair; ISS:UniProtKB.
DR GO; GO:0045750; P:positive regulation of S phase of mitotic cell cycle; IEA:Compara.
DR GO; GO:0043488; P:regulation of mRNA stability; ISS:UniProtKB.
DR GO; GO:0006355; P:regulation of transcription, DNA-dependent; IEA:UniProtKB-KW.
DR GO; GO:0042493; P:response to drug; IEA:Compara.
DR GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR InterPro; IPR020847; AP_endonuclease_F1_BS.
DR InterPro; IPR020848; AP_endonuclease_F1_CS.
DR InterPro; IPR005135; Endo/exonuclease/phosphatase.
DR InterPro; IPR004808; ExoDNase_III.
DR PANTHER; PTHR22748; PTHR22748; 1.
DR Pfam; PF03372; Exo_endo_phos; 1.
DR SUPFAM; SSF56219; Exo_endo_phos; 1.
DR TIGRFAMs; TIGR00633; xth; 1.
DR PROSITE; PS00726; AP_NUCLEASE_F1_1; 1.
DR PROSITE; PS00727; AP_NUCLEASE_F1_2; 1.
DR PROSITE; PS00728; AP_NUCLEASE_F1_3; 1.
DR PROSITE; PS51435; AP_NUCLEASE_F1_4; 1.
PE 1: Evidence at protein level;
KW Acetylation; Activator; Cleavage on pair of basic residues;
KW Complete proteome; Cytoplasm; Direct protein sequencing;
KW Disulfide bond; DNA damage; DNA recombination; DNA repair;
KW DNA-binding; Endonuclease; Endoplasmic reticulum; Exonuclease;
KW Hydrolase; Lyase; Magnesium; Metal-binding; Mitochondrion; Nuclease;
KW Nucleus; Phosphoprotein; Reference proteome; Repressor; RNA-binding;
KW S-nitrosylation; Transcription; Transcription regulation;
KW Ubl conjugation.
FT INIT_MET 1 1 Removed.
FT CHAIN 2 317 DNA-(apurinic or apyrimidinic site)
FT lyase.
FT /FTId=PRO_0000200011.
FT CHAIN 31 317 DNA-(apurinic or apyrimidinic site)
FT lyase, mitochondrial (By similarity).
FT /FTId=PRO_0000402573.
FT REGION 2 32 Necessary for interaction with YBX1,
FT binding to RNA, association together with
FT NPM1 to rRNA, endoribonuclease activity
FT on abasic RNA and localization in the
FT nucleoli (By similarity).
FT REGION 8 12 Nuclear localization signal (NLS) (By
FT similarity).
FT REGION 22 32 Necessary for interaction with NPM1 and
FT for efficient rRNA binding (By
FT similarity).
FT REGION 63 79 Nuclear export signal (NES) (By
FT similarity).
FT REGION 288 317 Mitochondrial targeting sequence (MTS)
FT (By similarity).
FT ACT_SITE 170 170 By similarity.
FT ACT_SITE 209 209 Proton donor/acceptor (By similarity).
FT METAL 69 69 Magnesium 1 (By similarity).
FT METAL 95 95 Magnesium 1 (By similarity).
FT METAL 209 209 Magnesium 2 (By similarity).
FT METAL 211 211 Magnesium 2 (By similarity).
FT METAL 307 307 Magnesium 1 (By similarity).
FT SITE 30 31 Cleavage; by granzyme A (By similarity).
FT SITE 211 211 Important for substrate recognition (By
FT similarity).
FT SITE 211 211 Transition state stabilizer (By
FT similarity).
FT SITE 282 282 Important for catalytic activity (By
FT similarity).
FT SITE 308 308 Interaction with DNA substrate (By
FT similarity).
FT MOD_RES 6 6 N6-acetyllysine; by EP300 (By
FT similarity).
FT MOD_RES 7 7 N6-acetyllysine; by EP300 (By
FT similarity).
FT MOD_RES 26 26 N6-acetyllysine (By similarity).
FT MOD_RES 30 30 N6-acetyllysine (By similarity).
FT MOD_RES 31 31 N6-acetyllysine (By similarity).
FT MOD_RES 34 34 N6-acetyllysine (By similarity).
FT MOD_RES 64 64 S-nitrosocysteine (By similarity).
FT MOD_RES 92 92 S-nitrosocysteine (By similarity).
FT MOD_RES 196 196 N6-acetyllysine (By similarity).
FT MOD_RES 232 232 Phosphothreonine; by CDK5.
FT MOD_RES 309 309 S-nitrosocysteine (By similarity).
FT DISULFID 64 92 By similarity.
FT MUTAGEN 53 53 S->A: Reduced CDK5-mediated
FT phosphorylation. Loss of CDK5-mediated
FT phosphorylation; when associated with T-
FT 232.
FT MUTAGEN 232 232 T->A: Reduced CDK5-mediated
FT phosphorylation. Confers neuron
FT resistance to MPP(+)/MPTP (1-methyl-4-
FT phenylpyridinium). Loss of CDK5-mediated
FT phosphorylation; when associated with S-
FT 53.
FT MUTAGEN 232 232 T->E: Confers neuron sensitivity to
FT MPP(+)/MPTP (1-methyl-4-
FT phenylpyridinium).
SQ SEQUENCE 317 AA; 35490 MW; CF086691FAC89C4A CRC64;
MPKRGKKAAA DDGEEPKSEP ETKKSKGAAK KTEKEAAGEG PVLYEDPPDQ KTSPSGKSAT
LKICSWNVDG LRAWIKKKGL DWVKEEAPDI LCLQETKCSE NKLPAELQEL PGLTHQYWSA
PSDKEGYSGV GLLSRQCPLK VSYGIGEEEH DQEGRVIVAE FESFVLVTAY VPNAGRGLVR
LEYRQRWDEA FRKFLKDLAS RKPLVLCGDL NVAHEEIDLR NPKGNKKNAG FTPQERQGFG
ELLQAVPLAD SFRHLYPNTA YAYTFWTYMM NARSKNVGWR LDYFLLSHSL LPALCDSKIR
SKALGSDHCP ITLYLAL
//
